New IBD and ulcerative colitis drug gets FDA approval: ‘astonishing results’
A new drug intended to treat a type of inflammatory bowel disease (IBD) has received the green light from the Food and Drug Administration. The FDA on Friday approved Pfizer’s etrasimod, branded as Velsipity, to treat adults with a chronic digestive disorder known as ulcerative colitis (UC). The oral pill, taken once a day, was …